INNATE PHARMA SA-SPONS ADR
IPHANASDAQ🏆 #3838 by market capEarnings Nov 5US Equity
$1.70▲ $0.11 (+6.25%)
LiveTrack IPHA
Get earnings, price moves & breaking news on Telegram
24h▲ 6.3%
7d▼ 5.6%
14d▼ 16.3%
30d▼ 23.1%
ytd▼ 4.5%
1y▼ 10.1%
🏦Market Cap
$160M
Small Cap
📈Revenue Growth (YoY)
-77.9%
Declining
📊Gross Margin
1770.3%
High
💵FCF Margin
-4108.2%
Thin
⚖️P/S Ratio
126.3x
Expensive
Otter Score
60
Fair
Earnings
Q3 · 2026Reported 2026-09-17Earnings Per Share
Actual
-0.24
Expected
-0.29
beat
+18.10%
Revenue
Actual
$6.50M
Expected
$6.35M
beat
+2.40%
Consensus estimates
Recent quarters
Q3 2026
-0.24
beat
Q2 2026
-0.35
beat
Q4 2025
-0.30
beat
Q2 2025
-0.35
miss